Team Financial Group’s Armata Pharmaceuticals ARMP Stock Holding History

Team Financial Group’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-71	Closed	-$727	–	65
2026 Q1	$727	Hold	71	–	–	﹤0.01%	264
2025 Q4	$446	Hold	71	–	–	﹤0.01%	261
2025 Q3	$212	Hold	71	–	–	﹤0.01%	257
2025 Q2	$135	Buy	+71	New	+$115	﹤0.01%	251
2024 Q1	–	Sell	-71	Closed	-$230	–	44
2023 Q4	$230	Hold	71	–	–	﹤0.01%	208
2023 Q3	$213	Buy	+71	New	+$190	﹤0.01%	195

Other funds holding ARMP

SWM

SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

CNBT

Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Team Financial Group's ARMP Position: Q2 2026 in Review

Team Financial Group sold out of Armata Pharmaceuticals (ARMP) in Q2 2026, closing a stake of 71 shares — an estimated $727 sold.

Team Financial Group first reported a position in ARMP in Q3 2023 and held it in 6 quarters. The position peaked at $727 in Q1 2026. 3 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

Team Financial Group reported no remaining Armata Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Team Financial Group sold 71 Armata Pharmaceuticals shares in Q2 2026, an estimated $727.
Team Financial Group first reported a position in Armata Pharmaceuticals in Q3 2023 and held it in 6 quarters.
Team Financial Group's Armata Pharmaceuticals position peaked at $727 in Q1 2026.
3 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Team Financial Group's 13F filing for Q2 2026, filed 13 Jul 2026.